Non-ST-elevation myocardial infarction with the use of oxymetazoline nasal spray

Rev Port Cardiol. 2014 Jan;33(1):51.e1-4. doi: 10.1016/j.repc.2013.07.011. Epub 2014 Jan 7.

Abstract

Oxymetazoline is an alpha-1 adrenergic receptor agonist that is commonly used for nasal decongestion and is readily available without a prescription. We report the case of a 64-year-old woman who developed prolonged chest pain associated with elevation of cardiac biomarkers after using oxymetazoline.

Keywords: Enfarte do miocárdio sem supradesnivelamento de ST; Non-ST-elevation myocardial infarction; Oximetazolina spray nasal; Oxymetazoline nasal spray.

Publication types

  • Case Reports

MeSH terms

  • Female
  • Humans
  • Middle Aged
  • Myocardial Infarction / chemically induced*
  • Nasal Decongestants / adverse effects*
  • Nasal Sprays
  • Oxymetazoline / adverse effects*

Substances

  • Nasal Decongestants
  • Nasal Sprays
  • Oxymetazoline